SPDR S&P Biotech ETF (XBI) sees strength amid more deal headlines
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) sees strength amid more deal headlines. Today it's PFE/GBT. The sector ETF is up 1.7%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Mulls Merger With Foreign Bank - Semafor
- BP plc weighing deals for oil-weighted shale assets worth $2B-$5B - Reuters
- Blue Origin Raises $10B At $140B Valuation - WSJ
Create E-mail Alert Related Categories
ETFs, Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
